UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 270

Sortiert nach

Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T‐cell lymphoma

British journal of haematology, 2018-11, Vol.183 (3), p.428-444

2018

Volltextzugriff (PDF)

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

The lancet oncology, 2018-09, Vol.19 (9), p.1192-1204

2018

Volltextzugriff (PDF)

Cardiac infiltration as complication of cutaneous T-lymphoblastic non-Hodgkin's lymphoma

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2007-02, Vol.179 (2), p.175

2007

Volltextzugriff (PDF)

Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial

Journal of clinical oncology, 2013-01, Vol.31 (1), p.104-110

2013

Volltextzugriff (PDF)

Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3109-3115

2007

Volltextzugriff (PDF)

Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides

Clinical cancer research, 2020-01, Vol.26 (2), p.408-418

2020

Volltextzugriff (PDF)

The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)

Clinical cancer research, 2015-06, Vol.21 (12), p.2820-2829

2015

Volltextzugriff (PDF)

MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma

Blood, 2014-03, Vol.123 (10), p.1499-1511

2014

Volltextzugriff (PDF)

KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting

Blood, 2017-12, Vol.130 (26), p.2900-2902

2017

Volltextzugriff (PDF)

Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma

International journal of radiation oncology, biology, physics, 2015-12, Vol.93 (5), p.1077-1086

2015

Volltextzugriff (PDF)

Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis

Journal of the American Academy of Dermatology, 2016-11, Vol.75 (5), p.992-999

2016

Volltextzugriff (PDF)

Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010

Journal of cutaneous medicine and surgery, 2018-03, Vol.22 (2), p.154-165

2018

Volltextzugriff (PDF)

Association of the numbers of CD163+ cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma

Journal of dermatological science, 2012-10, Vol.68 (1), p.45-51

2012

Volltextzugriff (PDF)

Cutaneous γδ T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas

The American journal of surgical pathology, 2012-11, Vol.36 (11), p.1656-1665

2012

Volltextzugriff (PDF)

Primary cutaneous NK/T-cell lymphoma of nasal type: an age-related lymphoproliferative disease?

Human pathology, 2017-10, Vol.68, p.61-68

2017

Volltextzugriff (PDF)

Primary Cutaneous Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients: A Multicenter European Case Series

American journal of transplantation, 2013-08, Vol.13 (8), p.2146-2153

2013

Volltextzugriff (PDF)

Romidepsin treatment for relapsed or refractory peripheral and cutaneous T‐cell lymphoma: Real‐life data from a national multicenter observational study

Hematological oncology, 2019-12, Vol.37 (5), p.569-577

2019

Volltextzugriff (PDF)

Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: A series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma

Journal of the American Academy of Dermatology, 2014-02, Vol.70 (2), p.318-325

2014

Volltextzugriff (PDF)

Incidence and survival patterns of cutaneous T-cell lymphomas in the United States

Leukemia & lymphoma, 2013-04, Vol.54 (4), p.752-759

2013

Volltextzugriff (PDF)

Brentuximab Vedotin in the Treatment of Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma

Current hematologic malignancy reports, 2020-02, Vol.15 (1), p.9-19

2020

Volltextzugriff (PDF)

Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma

Blood, 2015-02, Vol.125 (9), p.1435-1443

2015

Volltextzugriff (PDF)

Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma

Expert opinion on investigational drugs, 2007-07, Vol.16 (7), p.1111-1120

2007

Volltextzugriff (PDF)

Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type

Journal of the American Academy of Dermatology, 2015-06, Vol.72 (6), p.1016-1020

2015

Volltextzugriff (PDF)

1 – 25 von 270

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(231)

Publikationsform

Artikel
(270)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(262)
Life Sciences & Biomedicine
(226)
Science & Technology
(226)
Female
(193)
Male
(193)
Middle Aged
(181)
Lymphoma, T-Cell, Cutaneous - Mortality
(174)
Skin Neoplasms - Mortality
(169)
Aged
(155)
Adult
(149)
Skin Neoplasms - Pathology
(111)
Lymphoma, T-Cell, Cutaneous - Pathology
(108)
Aged, 80 And Over
(107)
Prognosis
(106)
Biological And Medical Sciences
(98)
Medical Sciences
(98)
Dermatology
(93)
Survival Rate
(91)
Neoplasm Staging
(80)
Oncology
(76)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T‐cell lymphoma

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Cardiac infiltration as complication of cutaneous T-lymphoblastic non-Hodgkin's lymphoma

Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases

Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial

Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides

The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)

MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma

KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting

Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma

Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis

Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010

Association of the numbers of CD163+ cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma

Cutaneous γδ T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas

Primary cutaneous NK/T-cell lymphoma of nasal type: an age-related lymphoproliferative disease?

Primary Cutaneous Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients: A Multicenter European Case Series

Romidepsin treatment for relapsed or refractory peripheral and cutaneous T‐cell lymphoma: Real‐life data from a national multicenter observational study

Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: A series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma

Incidence and survival patterns of cutaneous T-cell lymphomas in the United States

Brentuximab Vedotin in the Treatment of Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma

Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma

Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma

Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type

Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas

Suchergebnisse filtern